NCT06660758 Pilot Study of the Entarik System With Advanced Functionality in Health Adults
| NCT ID | NCT06660758 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gravitas Medical, Inc. |
| Condition | Healthy Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-10-22 |
| Primary Completion | 2025-12-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-10-22 with a primary completion date of 2025-12-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this single-site study, data will be recorded during nasogastric or orogastric placement (and post-pyloric placement) and removal of the Entarik Feeding Tube. Data will also be collected prior to, during, and following the delivery of a meal through the feeding tube.
Eligibility Criteria
Inclusion Criteria: 1. At least 18 years old 2. Able to provide informed consent 3. Capable and willing to follow all study-related procedures 4. Confirmed fasted state for a minimum of 8 hours prior to study initiation Exclusion Criteria: 1. Inability to receive a feeding tube 2. Known self-reported history of hiatal hernia, esophagitis, esophageal strictures or gastric ulcers 3. Has a basilar skull fracture 4. Self-reports pregnancy 5. Deemed unsuitable for enrollment in study by the investigator based on subjects' history or physical examination
Contact & Investigator
Thomas Sorrentino, MD
PRINCIPAL INVESTIGATOR
Frequently Asked Questions
Who can join the NCT06660758 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06660758 currently recruiting?
Yes, NCT06660758 is actively recruiting participants. Contact the research team at clinicalstudy@theranova.com for enrollment information.
Where is the NCT06660758 trial being conducted?
This trial is being conducted at Berkeley, United States.
Who is sponsoring the NCT06660758 clinical trial?
NCT06660758 is sponsored by Gravitas Medical, Inc.. The principal investigator is Thomas Sorrentino, MD. The trial plans to enroll 40 participants.